| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 1307-1314, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Nguyen, CL Corless, BM Kraling, C Tran, T Atha, J Bischoff and SH Barsky
Department of Surgery, University of California, Los Angeles 90095- 1782, USA.
Angiogenesis plays an important role in breast cancer growth and metastasis. Multiple adhesion molecules have been shown to perform critical functions in the process of angiogenesis. In this study, we analyzed 15 benign and 22 malignant estrogen-receptor-negative and estrogen-receptor-positive breast specimens for the presence of the endothelial cell adhesion molecules E-selectin and P-selectin. We found that E-selectin's expression was increased in the malignant breast tumors compared with their benign counterparts (23.86% of blood vessels versus 2.47%; P = 0.0005). Furthermore, E-selectin staining was found to be significantly increased in the estrogen-receptor-negative carcinomas compared with the estrogen-receptor-positive ones (P = 0.005). In vitro findings strongly correlated with the in vivo findings and showed a higher degree of E-selectin induction in endothelial cells exposed to conditioned media from estrogen-receptor-negative breast cancer cell lines than from estrogen-receptor-positive ones. The degree of E-selectin induction correlated with the amount of interleukin-1 alpha in the tumor-conditioned media. Neutralizing antibodies to interleukin-1 alpha significantly inhibited the E-selectin expression in endothelial cells exposed to tumor-conditioned media. The results indicate that the endothelial E-selectin expression during angiogenesis is related to breast carcinoma progression in vivo and that this component of angiogenesis may be due directly to tumor-cell-secreted interleukin-1 alpha.
This article has been cited by other articles:
![]() |
K. L. Streicher, N. E. Willmarth, J. Garcia, J. L. Boerner, T. G. Dewey, and S. P. Ethier Activation of a Nuclear Factor {kappa}B/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer Cells Mol. Cancer Res., August 1, 2007; 5(8): 847 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Stannard, R. Khurana, I. M. Evans, V. Sofra, D. I.R. Holmes, and I. Zachary Vascular Endothelial Growth Factor Synergistically Enhances Induction of E-Selectin by Tumor Necrosis Factor-{alpha} Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 494 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ramaswamy, A. D. Elias, N. T. Kelbick, A. Dodley, M. Morrow, M. Hauger, J. Allen, C. Rhoades, K. Kendra, H. X. Chen, et al. Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients. Clin. Cancer Res., May 15, 2006; 12(10): 3124 - 3129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lu, L. Zhang, R. S. Maul, M. R. Sartippour, A. Norris, J. Whitelegge, J. Y. Rao, and M. N. Brooks The Novel Gene EG-1 Stimulates Cellular Proliferation Cancer Res., July 15, 2005; 65(14): 6159 - 6166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, K. S. Moulton, M. K. Khan, S. Vineberg, E. Boye, V. M. Davis, P. E. O'Donnell, J. Bischoff, and D. S. Milstone E-selectin is required for the antiangiogenic activity of endostatin PNAS, May 25, 2004; 101(21): 8005 - 8010. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, R. S. Maul, J. Rao, S. Apple, D. Seligson, M. Sartippour, R. Rubio, and M. N. Brooks Expression Pattern of the Novel Gene EG-1 in Cancer Clin. Cancer Res., May 15, 2004; 10(10): 3504 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Niu, Z. Li, B. Peng, and P. J. Chiao Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1{alpha} in Induction of Constitutive NF-{kappa}B Activation in Pancreatic Cancer Cells J. Biol. Chem., April 16, 2004; 279(16): 16452 - 16462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Alpaugh, J. S. Tomlinson, Y. Ye, and S. H. Barsky Relationship of Sialyl-Lewisx/a Underexpression and E-Cadherin Overexpression in the Lymphovascular Embolus of Inflammatory Breast Carcinoma Am. J. Pathol., August 1, 2002; 161(2): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Volin, J. M. Woods, M. A. Amin, M. A. Connors, L. A. Harlow, and A. E. Koch Fractalkine: A Novel Angiogenic Chemokine in Rheumatoid Arthritis Am. J. Pathol., October 1, 2001; 159(4): 1521 - 1530. [Abstract] [Full Text] |
||||
![]() |
T. M. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tomlinson, S. H. Barsky, S. Nelson, S. Singer, B. Pezeshki, M. C. Lee, F. Eilber, and M. Nguyen Different Patterns of Angiogenesis in Sarcomas and Carcinomas Clin. Cancer Res., November 1, 1999; 5(11): 3516 - 3522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hebbar, F. Revillion, M.-M. Louchez, C. Fournier, J. Bonneterre, and J.-P. Peyrat Prognostic Value of Circulating Soluble E-Selectin Concentrations in Node-negative Breast Cancer Patients Clin. Cancer Res., June 1, 1999; 5(6): 1427 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Luo, G. Paranya, and J. Bischoff Noninflammatory Expression of E-Selectin Is Regulated by Cell Growth Blood, June 1, 1999; 93(11): 3785 - 3791. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bhat-Nakshatri, T. R. Newton, R. Goulet Jr., and H. Nakshatri NF-kappa B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha PNAS, June 9, 1998; 95(12): 6971 - 6976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |